Improved bioresorbable microporous intravascular stents for gene therapy

Yun Wei Ye, Charles Landau, Robert S. Meidell, John E. Willard, Ari Moskowitz, Sheza Aziz, Eric Carlisle, Kevin Nelson, Robert C. Eberhart

Research output: Contribution to journalArticlepeer-review

20 Scopus citations


Drug imbibing microporous stents are under development at a number of centers to enhance healing of the arterial wall after balloon coronary angioplasty procedures. The authors improved the mechanical strength and reservoir properties of a biodegradable microporous stent reported to this Society in 1994. A combined tubular/helical coil stent is readily fabricated by flotation/precipitation and casting/winding techniques. A two stage solvent swelling technique allows precise adjustment of the surface hydrophilic/hydrophobic balance. These developments permit seven-fold improvement in drug capacity without significantly altering mechanical properties. Stents modified in this manner retain tensile and compressive strength and are suitable for remote deployment. Elution kinetics of these modified stents suggest they are suitable for gene delivery. Successful gene transfer and transmural expression have been demonstrated after implantation of stents impregnated with a recombinant adenovirus carrying a nuclear localizing β-galactosidase reporter gene into rabbit carotid arteries. These studies suggest that surface modified, bioresorbable polymer stents ultimately may be useful adjunctive devices for gene transfer during percutaneous transluminal revascularization.

Original languageEnglish (US)
Pages (from-to)M823-M827
JournalASAIO Journal
Issue number5
StatePublished - 1996

ASJC Scopus subject areas

  • Biophysics
  • Bioengineering
  • Biomaterials
  • Biomedical Engineering


Dive into the research topics of 'Improved bioresorbable microporous intravascular stents for gene therapy'. Together they form a unique fingerprint.

Cite this